INIS
muscles
100%
mice
64%
hypoxia
48%
proteins
47%
inflammation
39%
atrophy
36%
patients
31%
diseases
31%
regulations
25%
oxidation
24%
kinases
20%
lungs
19%
mitochondria
17%
recovery
17%
receptors
15%
metabolism
14%
losses
14%
levels
12%
arginine
12%
plasma
11%
genes
11%
production
11%
phenotype
10%
synthesis
10%
glycogen
10%
cancer
10%
inactivation
9%
fasting
9%
ablation
9%
failures
8%
Keyphrases
Skeletal muscle
43%
Hypoxia
39%
Muscle Atrophy
34%
Protein Turnover
30%
Muscle Mass
25%
Chronic Obstructive Pulmonary Disease
19%
Pulmonary Inflammation
15%
Adaptation
14%
Chronic Hypoxia
13%
Muscle Protein Turnover
12%
Chronic Obstructive Pulmonary Disease Patient
12%
Protein Synthesis
12%
Inflammation
12%
Myogenesis
11%
Oxidative Phenotype
10%
Glycogen Synthase Kinase 3 (GSK3)
10%
Nuclear factor-κB
10%
Ablation
9%
Mouse Model
9%
Lung
9%
Mitochondrial Content
8%
Autophagosome
8%
Muscle Wasting
8%
Glycogen Synthase kinase-3β (GSK-3β)
7%
Induced Loss
7%
Chronic Respiratory Diseases
6%
Mass Recovery
6%
Mammalian Target of Rapamycin (mTOR)
6%
Myonuclear Accretion
6%
Adipose Tissue
6%
Medicine and Dentistry
Skeletal Muscle
33%
Hypoxia
29%
Protein Degradation
27%
Muscle Atrophy
26%
Chronic Obstructive Pulmonary Disease
16%
Muscle Protein
15%
Muscle Development
12%
Glycogen Synthase Kinase 3
10%
Autophagy
8%
Arginine
7%
Cachexia
6%
Chronic Respiratory Tract Disease
6%
Emphysema
6%
Skeletal Muscle Atrophy
5%
Immunoglobulin Enhancer Binding Protein
5%
Lung
5%
Protein Synthesis
5%
Messenger RNA
5%
